These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27587544)

  • 21. How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
    Gebhard A; van den Hof S; Cobelens F
    Am J Respir Crit Care Med; 2015 Jul; 192(1):117. PubMed ID: 26131997
    [No Abstract]   [Full Text] [Related]  

  • 22. Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
    Bastard M; Bonnet M; du Cros P; Khamraev AK; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Telnov A; Sanchez-Padilla E; Hewison C; Varaine F
    Am J Respir Crit Care Med; 2015 Jul; 192(1):117-8. PubMed ID: 26131996
    [No Abstract]   [Full Text] [Related]  

  • 23. Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union.
    van der Werf MJ; Hollo V; Ködmön C; Dara M; Catchpole M
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches.
    Dua K; Rapalli VK; Shukla SD; Singhvi G; Shastri MD; Chellappan DK; Satija S; Mehta M; Gulati M; Pinto TJA; Gupta G; Hansbro PM
    Biomed Pharmacother; 2018 Nov; 107():1218-1229. PubMed ID: 30257336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Multidrug-Resistant Tuberculosis Infection in Children.
    Cruz AT; Garcia-Prats AJ; Furin J; Seddon JA
    Pediatr Infect Dis J; 2018 Oct; 37(10):1061-1064. PubMed ID: 30216296
    [No Abstract]   [Full Text] [Related]  

  • 26. Multidrug resistant tuberculosis: a continuing crisis.
    Burki T
    Lancet Infect Dis; 2016 Dec; 16(12):1337-1338. PubMed ID: 27998601
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluoroquinolones resistance in multidrug-resistant tuberculosis in Pakistan and suitability of guidelines recommended standardized regimen.
    Ahmad N; Khan AH; Syed Sulaiman SA; Javaid A
    Int J Mycobacteriol; 2015 Sep; 4(3):258-9. PubMed ID: 27649876
    [No Abstract]   [Full Text] [Related]  

  • 28. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-resistant tuberculosis.
    Böttger EC
    Lancet; 2001 Apr; 357(9264):1288-9. PubMed ID: 11421208
    [No Abstract]   [Full Text] [Related]  

  • 30. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.
    Cox HS; Sibilia K; Feuerriegel S; Kalon S; Polonsky J; Khamraev AK; Rüsch-Gerdes S; Mills C; Niemann S
    N Engl J Med; 2008 Nov; 359(22):2398-400. PubMed ID: 19038891
    [No Abstract]   [Full Text] [Related]  

  • 31. Nomenclature of drug-resistant tuberculosis.
    Udwadia ZF; Amale RA; Ajbani KK; Rodrigues CS
    Lancet Infect Dis; 2013 Nov; 13(11):917. PubMed ID: 24156895
    [No Abstract]   [Full Text] [Related]  

  • 32. Challenges and Outlooks in Multi-drug Resistant Tuberculosis.
    Caminero Luna JA
    Arch Bronconeumol; 2017 Aug; 53(8):417-418. PubMed ID: 28314633
    [No Abstract]   [Full Text] [Related]  

  • 33. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistant plus susceptible tuberculosis: the undiscovered country.
    Ahmad Khan F; Behr M
    J Infect Dis; 2014 Jun; 209(11):1682-4. PubMed ID: 24523512
    [No Abstract]   [Full Text] [Related]  

  • 35. [Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat].
    Tärnvik A
    Lakartidningen; 2000 Nov; 97(48):5590-2. PubMed ID: 11187373
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug-resistant tuberculosis: reality and potential threat.
    Lalloo UG
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis.
    Van der Paardt AL; Akkerman OW; Gualano G; Palmieri F; Davies Forsman L; Aleksa A; Tiberi S; de Lange WC; Bolhuis MS; Skrahina A; van Soolingen D; Kosterink JG; Migliori GB; van der Werf TS; Alffenaar JC
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331034
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluoroquinolones in multidrug-resistant tuberculosis.
    Mohapatra PR
    Am J Respir Crit Care Med; 2004 Oct; 170(8):920-1. PubMed ID: 15475406
    [No Abstract]   [Full Text] [Related]  

  • 39. Update treatment of multidrug-resistant tuberculosis. Introduction, discussion and summary.
    Youngchaiyud P; Iseman MD
    Chemotherapy; 1999; 45 Suppl 2():1-2, 41-5. PubMed ID: 10523129
    [No Abstract]   [Full Text] [Related]  

  • 40. Programmatic management of multidrug-resistant tuberculosis--15 years later.
    Nardell EA
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1280. PubMed ID: 22283883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.